Business
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.
HIMSS25
From documenting bedside prayers to helping a hard-of-hearing nurse connect with patients, AI tools are revealing the importance of nurses' and patients' emotional and spiritual bonds to healing, says Mercy's Tracy Breece.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
The company's valuation has increased by $1 billion since its $130 million Series E funding round last year.
HIMSS25
According to Tony DiGiorgio, chief architect at Symplr, the company has carefully embedded AI into its operational platform to cut administrative redundancy and enable nurses to minimize the number of systems they use each day.
Nissan Elimelech, founder of Augmedics, shares how the company's augmented reality surgical technology projects an anatomically accurate 3D spine onto the patient, helping surgeons operate with their eyes on the body instead of a screen.
HIMSS25
Regina Wysocki, senior informatics program manager at Lone Star Communications, says centralizing health system data provides nurses with a "bigger picture" of operations so they can uncover trends that can improve care delivery.
Wojcicki, cofounder and former CEO of 23andMe, is set to reacquire the company through her nonprofit, TTAM Research Institute.